PROSFYND
Dead / Abandoned — Abandoned — failure to respond (as of 13 Apr 2023)
What this means for you
This application is over — abandoned 28 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97305379
- Mark type
- Stylized text
- Filed
- 10 Mar 2022
- Abandoned
- 28 Mar 2023
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis, prevention, treatment and monitoring of cancer
- Class 009 — Scientific and electric apparatus: downloadable and embedded medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer; software for use in medical imaging
- Class 042 — Scientific and technological services: scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer
- Class 044 — Medical, beauty and agricultural services: providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services
Owner
- Progenics Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 13 Apr 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 13 Apr 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 13 Apr 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Dec 2022 — NON-FINAL ACTION E-MAILED
- 27 Dec 2022 — NON-FINAL ACTION WRITTEN
- 21 Dec 2022 — ASSIGNED TO EXAMINER
- 15 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Mar 2022 — NEW APPLICATION ENTERED